Former AIIMS director and senior pulmonologist, Dr Randeep Guleria said that the new subvariant of COVID is not causing severe infections and hospitalisation.
Amid a surge in COVID cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is required against the subvariant at the present stage.
NITI Aayog member Dr. VK Paul on Wednesday asked fellow citizens not to panic about the new COVID-19 variant JN.1 and assured that the Centre is taking the necessary precautions to combat the new variant.
The latest preprint new study shows XBB.1.16 Omicron variant, which is behind the COVID surge in India and will also spread worldwide in the near future, has an effective reproductive number (Re) 1.27 and 1.17-fold higher respectively than XBB.1 & XBB.1.5, suggesting that XBB.1.16 will s
Washington [US], October 19 (ANI): Researchers analyzed the structures of the receptor-binding domain (RBD) of the SARS-CoV-2 omicron variant and its receptor, angiotensin-converting enzyme 2 (ACE2), to gain insight into the variant's potential animal reservoir.